← Back to All Filings

Seilern Investment's Q3 Holdings: $1.38B in Assets Reported

Medium SignificanceOctober 14, 2025 at 8:05:22 AM EDT

Filing Summary

Seilern Investment's Q3 Holdings: $1.38B in Assets Reported

Filer: Seilern Investment Management Ltd Form: 13F-HR | Filed: 2025-10-14 Significance: Medium

Portfolio Summary: • Total Value: $1,383,600,780 • Number of Holdings: 22 • Report Date: 2025-09-30

Top 5 Holdings (by Value):

  1. UnitedHealth Group ($133.2M)
  2. Microsoft Corp ($131.8M)
  3. Mastercard Inc ($128.8M)
  4. Alphabet Inc ($106.4M)
  5. IDEXX Labs Inc ($90.3M)

Key Insight: London-based Seilern Investment Management has disclosed its Q3 2025 portfolio, revealing a concentrated strategy with 22 holdings valued at nearly $1.4 billion. The portfolio shows a strong conviction in large-cap US tech, healthcare, and financial services companies.

View Full Filing

This is PUBLIC SEC data for educational purposes. Not investment advice.

Comprehensive Analysis

SEC Filing Analysis: Seilern Investment Management Ltd

Executive Summary

  • Trading Significance: Medium
  • Key Takeaway: Seilern Investment Management Ltd filed its quarterly Form 13F-HR, disclosing $1.38 billion in assets under management across a concentrated portfolio of 22 holdings as of September 30, 2025. The portfolio is heavily weighted towards large-cap growth stocks in the technology, healthcare, and financial sectors.
  • Market Impact: This filing provides transparency into the firm's high-conviction bets. While 13F data is backward-looking, it is closely watched by the market to gauge institutional sentiment and identify trends in money flow. The firm's positions in major names like UnitedHealth, Microsoft, and Mastercard reinforce a bullish stance on quality growth.

Filer Information

FieldValue
Filer NameSeilern Investment Management Ltd
CIK0001817797
TypeInstitutional Investment Manager

Portfolio Summary

FieldValue
Form Type13F-HR
Filing Date2025-10-14
Period of Report Date2025-09-30
Total Portfolio Value$1,383,600,780
Number of Holdings22

Top 5 Holdings

IssuerValue (USD)Shares
UnitedHealth Group Inc$133,189,116385,720
Microsoft Corp$131,841,065254,544
Mastercard Incorporated$128,800,199226,438
Alphabet Inc$106,363,300437,529
IDEXX Labs Inc$90,259,824141,276

Market Impact Analysis

Stock Impact Prediction

  • Direction: Neutral to Positive for top holdings.
  • Reasoning: This filing confirms a significant institutional holder maintains large positions in these companies, which can be seen as a vote of confidence. However, as this is a regular quarterly disclosure and the data is over a month old, it is unlikely to cause a sharp, immediate price movement. The primary value is in long-term trend analysis.

Volume & Sentiment

  • Expected Volume Impact: Minimal. 13F filings are widely anticipated and do not typically trigger significant short-term volume spikes.
  • Sentiment Indicator: Bullish on Quality Growth. The portfolio composition indicates a clear strategy of investing in established, market-leading companies with strong competitive advantages and growth runways.

Investment Insights

Positive Market Indicators

  • High-Conviction Bets: A concentrated portfolio of only 22 stocks suggests a high degree of research and conviction in each position.
  • Focus on Dominant Players: The top holdings are dominant companies in their respective industries (Healthcare, Software, Payments, Digital Advertising), indicating a preference for durable, wide-moat businesses.
  • Consistent Strategy: Comparing this filing to previous ones would reveal the manager's buy/sell decisions and holding periods, offering deeper insights into their investment philosophy.

Risk Factors

  • Lagged Data: The holdings are reported as of September 30, 2025. The firm could have altered these positions in the 45 days between the report date and the filing date.
  • Concentration Risk: While indicating conviction, a concentrated portfolio is also subject to higher volatility if one of its core sectors or holdings underperforms.

Key Takeaways

  1. Portfolio Value: Seilern Investment Management reported a total portfolio value of $1.38 billion.
  2. Concentrated Strategy: The firm holds a focused portfolio of 22 securities, indicating high-conviction investment decisions.
  3. Sector Focus: The portfolio is heavily weighted towards Technology, Healthcare, and Financial Services, with top holdings in UnitedHealth, Microsoft, and Mastercard.

Contextual Analysis

Timing Significance

This is a mandatory quarterly report filed within 45 days of the quarter's end (September 30). The timing is standard and in line with regulatory requirements for institutional investment managers with over $100 million in qualifying assets.

Transaction Context

Form 13F-HR discloses long positions as of a specific date and does not detail individual buy or sell transactions that occurred during the quarter. It also does not include short positions, certain options, or other derivative instruments, providing an incomplete picture of the firm's overall strategy.

Company Context

Seilern Investment Management Ltd is a London-based investment firm. This filing provides a snapshot of its US-listed equity holdings, which form a core part of its investment strategy.

Risk Assessment

Risk Level: Low

Risk Factors for Interpretation

  • Backward-Looking: The data is 45 days old and may not reflect the current portfolio.
  • Incomplete Picture: The filing does not show cash positions, short positions, or non-US holdings.
  • No 'Why': The filing shows what the firm holds, but not why they initiated or maintained the position.

IMPORTANT DISCLAIMER: This analysis is for informational purposes only and is not intended as investment advice. The information presented is based on publicly available SEC filings and should not be construed as a recommendation to buy, sell, or hold any securities. Past performance does not guarantee future results. All investments carry risk, including the potential loss of principal. Please consult with a qualified financial advisor before making any investment decisions.

Analysis generated on 2025-10-14 | Data source: SEC EDGAR

Topics:#SECFiling#Form13F#13FHR#SeilernInvestment#InstitutionalInvesting#PortfolioDisclosure#StockMarket#Investing#Finance#MarketAnalysis

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.

Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.